Filing Details

Accession Number:
0001569706-18-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-06 17:26:40
Reporting Period:
2018-10-29
Accepted Time:
2018-11-06 17:26:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1018735 Nymox Pharmaceutical Corp NYMX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569706 Paul Averback C/o Nymox Pharmaceutical Corporation
9900 Cavendish Blvd., Suite 306
St. Laurent A8 H4M 2V2
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Restricted Common Disposition 2018-10-29 1,687,600 $2.50 21,643,948 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct